Top Markets
Coin of the day
NewcelX Ltd. NewcelX Ltd.

NewcelX Ltd.

NCEL
Rank in Stocks #37735
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich,... NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Share Price
$3.29
Last synced: 2026-08-14
Market Cap
$1.48M
Change (1 day)
-8.63%
Change (1 year)
-86.89%
Country
CH
Trade NewcelX Ltd. (NCEL)

Category

Operating Margin for NewcelX Ltd. (NCEL)
Operating Margin as of 2026 TTM: 0.00%
According to NewcelX Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for NewcelX Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.